These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 27889572)

  • 1. SMAD About Hepatitis C Virus Cell Entry and Liver Disease.
    Colpitts CC; Baumert TF
    Gastroenterology; 2017 Jan; 152(1):21-23. PubMed ID: 27889572
    [No Abstract]   [Full Text] [Related]  

  • 2. Infection of Hepatocytes With HCV Increases Cell Surface Levels of Heparan Sulfate Proteoglycans, Uptake of Cholesterol and Lipoprotein, and Virus Entry by Up-regulating SMAD6 and SMAD7.
    Zhang F; Sodroski C; Cha H; Li Q; Liang TJ
    Gastroenterology; 2017 Jan; 152(1):257-270.e7. PubMed ID: 27693511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipoprotein lipase mediates hepatitis C virus (HCV) cell entry and inhibits HCV infection.
    Andréo U; Maillard P; Kalinina O; Walic M; Meurs E; Martinot M; Marcellin P; Budkowska A
    Cell Microbiol; 2007 Oct; 9(10):2445-56. PubMed ID: 17517063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C virus, cholesterol and lipoproteins--impact for the viral life cycle and pathogenesis of liver disease.
    Felmlee DJ; Hafirassou ML; Lefevre M; Baumert TF; Schuster C
    Viruses; 2013 May; 5(5):1292-324. PubMed ID: 23698400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of hepatitis C virus interaction with heparan sulfate proteoglycans.
    Xu Y; Martinez P; Séron K; Luo G; Allain F; Dubuisson J; Belouzard S
    J Virol; 2015 Apr; 89(7):3846-58. PubMed ID: 25609801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smad7 deficiency decreases iron and haemoglobin through hepcidin up-regulation by multilayer compensatory mechanisms.
    An P; Wang H; Wu Q; Wang J; Xia Z; He X; Wang X; Chen Y; Min J; Wang F
    J Cell Mol Med; 2018 Jun; 22(6):3035-3044. PubMed ID: 29575577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein E mediates attachment of clinical hepatitis C virus to hepatocytes by binding to cell surface heparan sulfate proteoglycan receptors.
    Jiang J; Wu X; Tang H; Luo G
    PLoS One; 2013; 8(7):e67982. PubMed ID: 23844141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Syndecan 4 is involved in mediating HCV entry through interaction with lipoviral particle-associated apolipoprotein E.
    Lefèvre M; Felmlee DJ; Parnot M; Baumert TF; Schuster C
    PLoS One; 2014; 9(4):e95550. PubMed ID: 24751902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategies to inhibit entry of HBV and HDV into hepatocytes.
    Urban S; Bartenschlager R; Kubitz R; Zoulim F
    Gastroenterology; 2014 Jul; 147(1):48-64. PubMed ID: 24768844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How hepatitis C virus invades hepatocytes: the mystery of viral entry.
    Zhu YZ; Qian XJ; Zhao P; Qi ZT
    World J Gastroenterol; 2014 Apr; 20(13):3457-67. PubMed ID: 24707128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C virus utilizes VLDLR as a novel entry pathway.
    Ujino S; Nishitsuji H; Hishiki T; Sugiyama K; Takaku H; Shimotohno K
    Proc Natl Acad Sci U S A; 2016 Jan; 113(1):188-93. PubMed ID: 26699506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Up-regulation of the ATP-binding cassette transporter A1 inhibits hepatitis C virus infection.
    Bocchetta S; Maillard P; Yamamoto M; Gondeau C; Douam F; Lebreton S; Lagaye S; Pol S; Helle F; Plengpanich W; Guérin M; Bourgine M; Michel ML; Lavillette D; Roingeard P; le Goff W; Budkowska A
    PLoS One; 2014; 9(3):e92140. PubMed ID: 24646941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of glycosaminoglycans for binding and infection of hepatitis B virus.
    Leistner CM; Gruen-Bernhard S; Glebe D
    Cell Microbiol; 2008 Jan; 10(1):122-33. PubMed ID: 18086046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C virus relies on lipoproteins for its life cycle.
    Grassi G; Di Caprio G; Fimia GM; Ippolito G; Tripodi M; Alonzi T
    World J Gastroenterol; 2016 Feb; 22(6):1953-65. PubMed ID: 26877603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The hepatitis C virus and its hepatic environment: a toxic but finely tuned partnership.
    Perrault M; Pécheur EI
    Biochem J; 2009 Oct; 423(3):303-14. PubMed ID: 19807698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of hepatitis C virus entry on viral tropism.
    Ding Q; von Schaewen M; Ploss A
    Cell Host Microbe; 2014 Nov; 16(5):562-8. PubMed ID: 25525789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virology: Final entry key for hepatitis C.
    Pietschmann T
    Nature; 2009 Feb; 457(7231):797-8. PubMed ID: 19212389
    [No Abstract]   [Full Text] [Related]  

  • 18. Hepatitis C virus cell entry: role of lipoproteins and cellular receptors.
    Burlone ME; Budkowska A
    J Gen Virol; 2009 May; 90(Pt 5):1055-1070. PubMed ID: 19264629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smad6 and Smad7 are co-regulated with hepcidin in mouse models of iron overload.
    Vujić Spasić M; Sparla R; Mleczko-Sanecka K; Migas MC; Breitkopf-Heinlein K; Dooley S; Vaulont S; Fleming RE; Muckenthaler MU
    Biochim Biophys Acta; 2013 Jan; 1832(1):76-84. PubMed ID: 22960056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Entry of pseudotyped hepatitis C virus into primary human hepatocytes depends on the scavenger class B type I receptor.
    Régeard M; Trotard M; Lepère C; Gripon P; Le Seyec J
    J Viral Hepat; 2008 Dec; 15(12):865-70. PubMed ID: 19087225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.